Cheung NV - Search Results

1

Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.

Yesmin F, Bhuiyan RH, Ohmi Y, Yamamoto S, Kaneko K, Ohkawa Y, Zhang P, Hamamura K, Cheung NV, Kotani N, Honke K, Okajima T, Kambe M, Tajima O, Furukawa K, Furukawa K. Yesmin F, et al. Among authors: cheung nv. Int J Mol Sci. 2021 Dec 31;23(1):423. doi: 10.3390/ijms23010423. Int J Mol Sci. 2021. PMID: 35008849 Free PMC article.

2

GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma.

Park JA, Cheung NV. Park JA, et al. Among authors: cheung nv. J Hematol Oncol. 2020 Dec 10;13(1):172. doi: 10.1186/s13045-020-01012-y. J Hematol Oncol. 2020. PMID: 33303017 Free PMC article.

3

Promise and Challenges of T Cell Immunotherapy for Osteosarcoma.

Park JA, Cheung NV. Park JA, et al. Among authors: cheung nv. Int J Mol Sci. 2023 Aug 7;24(15):12520. doi: 10.3390/ijms241512520. Int J Mol Sci. 2023. PMID: 37569894 Free PMC article. Review.

4

Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial.

Grant SC, Kostakoglu L, Kris MG, Yeh SD, Larson SM, Finn RD, Oettgen HF, Cheung NV. Grant SC, et al. Among authors: cheung nv. Eur J Nucl Med. 1996 Feb;23(2):145-9. doi: 10.1007/BF01731837. Eur J Nucl Med. 1996. PMID: 8925848 Clinical Trial.

5

Treatment and outcome of adult-onset neuroblastoma.

Suzuki M, Kushner BH, Kramer K, Basu EM, Roberts SS, Hammond WJ, LaQuaglia MP, Wolden SL, Cheung NV, Modak S. Suzuki M, et al. Among authors: cheung nv. Int J Cancer. 2018 Sep 1;143(5):1249-1258. doi: 10.1002/ijc.31399. Epub 2018 Apr 6. Int J Cancer. 2018. PMID: 29574715 Free PMC article.

6

Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression.

Cheung IY, Cheung NV, Modak S, Mauguen A, Feng Y, Basu E, Roberts SS, Ragupathi G, Kushner BH. Cheung IY, et al. Among authors: cheung nv. J Clin Oncol. 2021 Jan 20;39(3):215-226. doi: 10.1200/JCO.20.01892. Epub 2020 Dec 16. J Clin Oncol. 2021. PMID: 33326254 Free PMC article. Clinical Trial.

7

Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody.

Nakajima M, Guo HF, Hoseini SS, Suzuki M, Xu H, Cheung NV. Nakajima M, et al. Among authors: cheung nv. Pediatr Blood Cancer. 2021 Jul;68(7):e28971. doi: 10.1002/pbc.28971. Epub 2021 Apr 12. Pediatr Blood Cancer. 2021. PMID: 33844437 Free PMC article.

8

Immunotherapy with anti-G_D2 monoclonal antibody in infants with high-risk neuroblastoma.

Kushner BH, Modak S, Kramer K, Basu EM, Iglesias-Cardenas F, Roberts SS, Cheung NV. Kushner BH, et al. Among authors: cheung nv. Int J Cancer. 2023 Jan 15;152(2):259-266. doi: 10.1002/ijc.34233. Epub 2022 Aug 17. Int J Cancer. 2023. PMID: 35913764 Free article.

9

Stage 4N neuroblastoma before and during the era of anti-G_D2 immunotherapy.

Kushner BH, LaQuaglia MP, Cardenas FI, Basu EM, Gerstle JT, Kramer K, Roberts SS, Wolden SL, Cheung NV, Modak S. Kushner BH, et al. Among authors: cheung nv. Int J Cancer. 2023 Dec 15;153(12):2019-2031. doi: 10.1002/ijc.34693. Epub 2023 Aug 21. Int J Cancer. 2023. PMID: 37602920

10

A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.

Kushner BH, Cheung NV, Modak S, Becher OJ, Basu EM, Roberts SS, Kramer K, Dunkel IJ. Kushner BH, et al. Among authors: cheung nv. Int J Cancer. 2017 Jan 15;140(2):480-484. doi: 10.1002/ijc.30440. Epub 2016 Sep 30. Int J Cancer. 2017. PMID: 27649927 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page